Heart Failure 2024: Cutting-edge science and stimulating discussions in heart failure management

Cutting edge science and stimulating discussions in heart failure management are in store at Heart Failure 2024, a scientific congress of the European Society of Cardiology (ESC).

Pharmalittle: Bioscience job market is upside down; Sanofi and Regeneron’s blockbuster Dupixent may find bigger market

Good morning, everyone, and nice to see you again after an extended break on this side of the pond. We hope your own respite was

November 27, 2023

EMA CHMP recommends Takeda’s Hyqvia for CIDP treatment

Share this article Takeda’s Hyqvia is intended for usage as a maintenance treatment following stabilisation with IVIG. Credit: Tada Images / Shutterstock.com. The Committee for

December 18, 2023

AI-based models can outperform human experts at identifying ovarian cancer

A new international study led by researchers at Karolinska Institutet in Sweden shows that AI-based models can outperform human experts at identifying ovarian cancer in

January 2, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.